TP53 wt Allele Active Not Recruiting Phase 2 Trials for Fludeoxyglucose (18F) (DB09502)
Indication | Status | Phase |
---|---|---|
DBCOND0082200 (TP53 wt Allele) | Active Not Recruiting | 2 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT03732352 | 18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients With EGFR Activated Recurrent Glioblastoma | Treatment |